Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$1.89M Sell
17,754
-439
-2% -$47.4K 0.53% 50
2022
Q4
$2.02M Buy
18,193
+640
+4% +$65.4K 0.56% 47
2022
Q3
$1.51M Sell
17,553
-442
-2% -$39.5K 0.44% 59
2022
Q2
$1.64M Sell
17,995
-128
-0.7% -$11.3K 0.45% 57
2022
Q1
$1.49M Sell
18,123
-342
-2% -$27K 0.35% 68
2021
Q4
$1.42M Buy
18,465
+791
+4% +$63K 0.32% 74
2021
Q3
$1.33M Buy
17,674
+718
+4% +$54.6K 0.33% 69
2021
Q2
$1.32M Sell
16,956
-275
-2% -$20.5K 0.35% 70
2021
Q1
$1.27M Sell
17,231
-73
-0.4% -$5.38K 0.38% 67
2020
Q4
$1.35M Buy
17,304
+7,107
+70% +$544K 0.44% 56
2020
Q3
$782K Sell
10,197
-157
-2% -$12.3K 0.29% 76
2020
Q2
$778K Sell
10,354
-62,975
-86% -$4.74M 0.32% 67
2020
Q1
$5.5M Buy
73,329
+70,316
+2,334% +$5.53M 0.82% 32
2019
Q4
$257K Sell
3,013
-9
-0.3% -$739 0.11% 102
2019
Q3
$239K Sell
3,022
-26
-0.9% -$2.08K 0.13% 101
2019
Q2
$244K Buy
3,048
+1
+0% +$77 0.14% 93
2019
Q1
$242K Sell
3,047
-25
-0.8% -$1.87K 0.15% 96
2018
Q4
$224K Buy
+3,072
New +$217K 0.15% 100

Other funds holding MRK

HNP Capital's MRK Position: Q1 2023 in Review

HNP Capital reduced its Merck (MRK) stake by 2.4% in Q1 2023, selling an estimated $47.4K and leaving 17,754 shares worth $1.89M. The position accounts for 0.53% of the portfolio, ranked #50.

HNP Capital first reported a position in MRK in Q4 2018 and has held it in 18 quarters since. The position peaked at $5.5M in Q1 2020. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • HNP Capital held 17,754 shares of Merck worth $1.89M as of Q1 2023.
  • HNP Capital sold 439 Merck shares in Q1 2023, an estimated $47.4K.
  • Merck made up 0.53% of HNP Capital's portfolio in Q1 2023, its #50 holding.
  • HNP Capital first reported a position in Merck in Q4 2018 and has held it in 18 quarters since.
  • HNP Capital's Merck position peaked at $5.5M in Q1 2020.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.